Skip to main content
Log in

The OPA1 Gene Mutations Are Frequent in Han Chinese Patients with Suspected Optic Neuropathy

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

While many patients with hereditary optic neuropathies are caused by mitochondrial DNA (mtDNA) mutations of Leber’s hereditary optic neuropathy (LHON), a significant proportion of them does not have mtDNA mutation and is caused by mutations in genes of the nuclear genome. In this study, we investigated whether the OPA1 gene, which is a pathogenic gene for autosomal dominant optic atrophy (ADOA), is frequently mutated in these patients. We sequenced all 29 exons of the OPA1 gene in 105 Han Chinese patients with suspected LHON. mtDNA copy number was quantified in blood samples from patients with and without OPA1 mutation and compared to healthy controls. In silico program-affiliated prediction, evolutionary conservation analysis, and in vitro cellular assays were performed to show the potential pathogenicity of the mutations. We identified nine OPA1 mutations in eight patients; six of them are located in exons and three are located in splicing sites. Mutation c.1172T > G has not been reported before. When we combined our data with 193 reported Han Chinese patients with optic neuropathy and compared to the available data of 4327 East Asians by the Exome Aggregation Consortium (ExAC), we found a significant enrichment of potentially pathogenic OPA1 mutations in Chinese patients. Cellular assays for OPA1 mutants c.869G > A and c.2708_2711del showed abnormalities in OPA1 isoforms, mitochondrial morphology, and cellular reactive oxygen species (ROS) level. Our results indicated that screening OPA1 mutation is needed for clinical diagnosis of patients with suspected optic neuropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF (2009) Inherited mitochondrial optic neuropathies. J Med Genet 46(3):145–158

    Article  CAS  PubMed  Google Scholar 

  2. Hoppins S, Lackner L, Nunnari J (2007) The machines that divide and fuse mitochondria. Annu Rev Biochem 76:751–780

    Article  CAS  PubMed  Google Scholar 

  3. Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, Bartoli D, Polishuck RS et al (2006) OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126(1):177–189

    Article  CAS  PubMed  Google Scholar 

  4. Olichon A, Baricault L, Gas N, Guillou E, Valette A, Belenguer P, Lenaers G (2003) Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 278(10):7743–7746

    Article  CAS  PubMed  Google Scholar 

  5. Kushnareva YE, Gerencser AA, Bossy B, Ju WK, White AD, Waggoner J, Ellisman MH, Perkins G et al (2013) Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity. Cell Death Differ 20(2):353–365

    Article  CAS  PubMed  Google Scholar 

  6. Wang AG, Fann MJ, Yu HY, Yen MY (2006) OPA1 expression in the human retina and optic nerve. Exp Eye Res 83(5):1171–1178

    Article  CAS  PubMed  Google Scholar 

  7. Yu-Wai-Man P, Shankar SP, Biousse V, Miller NR, Bean LJ, Coffee B, Hegde M, Newman NJ (2011) Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies. Ophthalmology 118(3):558–563

    Article  PubMed  Google Scholar 

  8. Zhang AM, Jia X, Bi R, Salas A, Li S, Xiao X, Wang P, Guo X et al (2011) Mitochondrial DNA haplogroup background affects LHON, but not suspected LHON, in Chinese patients. PLoS One 6(11), e27750

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Feng YM, Jia YF, Su LY, Wang D, Lv L, Xu L, Yao YG (2013) Decreased mitochondrial DNA copy number in the hippocampus and peripheral blood during opiate addiction is mediated by autophagy and can be salvaged by melatonin. Autophagy 9(9):1395–1406

    Article  CAS  PubMed  Google Scholar 

  10. Bi R, Zhang AM, Zhang W, Kong QP, Wu BL, Yang XH, Wang D, Zou Y et al (2010) The acquisition of an inheritable 50-bp deletion in the human mtDNA control region does not affect the mtDNA copy number in peripheral blood cells. Hum Mutat 31(5):538–543

    CAS  PubMed  Google Scholar 

  11. Bi R, Zhang W, Yu D, Li X, Wang HZ, Hu QX, Zhang C, Lu W et al (2015) Mitochondrial DNA haplogroup B5 confers genetic susceptibility to Alzheimer’s disease in Han Chinese. Neurobiol Aging 36(3):1604. e7

    Article  CAS  Google Scholar 

  12. Guo H, Zhuang XY, Zhang AM, Zhang W, Yuan Y, Guo L, Yu D, Liu J et al (2012) Presence of mutation m.14484T > C in a Chinese family with maternally inherited essential hypertension but no expression of LHON. Biochim Biophys Acta 1822(10):1535–1543

    Article  CAS  PubMed  Google Scholar 

  13. Ferre M, Amati-Bonneau P, Tourmen Y, Malthiery Y, Reynier P (2005) eOPA1: an online database for OPA1 mutations. Hum Mutat 25(5):423–428

    Article  CAS  PubMed  Google Scholar 

  14. Ferre M, Caignard A, Milea D, Leruez S, Cassereau J, Chevrollier A, Amati-Bonneau P, Verny C et al (2015) Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical data. Hum Mutat 36(1):20–25

    Article  CAS  PubMed  Google Scholar 

  15. Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Current protocols in human genetics/editorial board, Jonathan L Haines [et al.] Chapter 7:Unit7 20

  16. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248–249

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Chun S, Fay JC (2009) Identification of deleterious mutations within three human genomes. Genome Res 19(9):1553–1561

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Schwarz JM, Cooper DN, Schuelke M, Seelow D (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11(4):361–362

    Article  CAS  PubMed  Google Scholar 

  19. Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4(7):1073–1081

    Article  CAS  PubMed  Google Scholar 

  20. Ng PC, Henikoff S (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31(13):3812–3814

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Chen Y, Jia X, Wang P, Xiao X, Li S, Guo X, Zhang Q (2013) Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy. Mol Vis 19:292–302

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Elachouri G, Vidoni S, Zanna C, Pattyn A, Boukhaddaoui H, Gaget K, Yu-Wai-Man P, Gasparre G et al (2011) OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution. Genome Res 21(1):12–20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J et al (2000) Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 26(2):207–210

    Article  CAS  PubMed  Google Scholar 

  24. Tonska K, Kodron A, Bartnik E (2010) Genotype-phenotype correlations in Leber hereditary optic neuropathy. Biochim Biophys Acta 1797(6–7):1119–1123

    Article  CAS  PubMed  Google Scholar 

  25. Chen J, Xu K, Zhang X, Jiang F, Liu L, Dong B, Ren Y, Li Y (2014) Mutation screening of mitochondrial DNA as well as OPA1 and OPA3 in a Chinese cohort with suspected hereditary optic atrophy. Invest Ophthalmol Vis Sci 55(10):6987–6995

    Article  CAS  PubMed  Google Scholar 

  26. Kamakari S, Koutsodontis G, Tsilimbaris M, Fitsios A, Chrousos G (2014) First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation. Mol Vis 20:691–703

    PubMed  PubMed Central  Google Scholar 

  27. Liskova P, Ulmanova O, Tesina P, Melsova H, Diblik P, Hansikova H, Tesarova M, Votruba M (2013) Novel OPA1 missense mutation in a family with optic atrophy and severe widespread neurological disorder. Acta Ophthalmol (Copenh) 91(3):e225–e231

    Article  CAS  Google Scholar 

  28. Yu-Wai-Man P, Stewart JD, Hudson G, Andrews RM, Griffiths PG, Birch MK, Chinnery PF (2010) OPA1 increases the risk of normal but not high tension glaucoma. J Med Genet 47(2):120–125

    Article  CAS  PubMed  Google Scholar 

  29. Olichon A, Landes T, Arnaune-Pelloquin L, Emorine LJ, Mils V, Guichet A, Delettre C, Hamel C et al (2007) Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis. J Cell Physiol 211(2):423–430

    Article  CAS  PubMed  Google Scholar 

  30. Pesch UE, Leo-Kottler B, Mayer S, Jurklies B, Kellner U, Apfelstedt-Sylla E, Zrenner E, Alexander C et al (2001) OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance. Hum Mol Genet 10(13):1359–1368

    Article  CAS  PubMed  Google Scholar 

  31. Lodi R, Tonon C, Valentino ML, Iotti S, Clementi V, Malucelli E, Barboni P, Longanesi L et al (2004) Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. Ann Neurol 56(5):719–723

    Article  CAS  PubMed  Google Scholar 

  32. Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, Auer-Grumbach M, Toscano A, Musumeci O et al (2010) Multi-system neurological disease is common in patients with OPA1 mutations. Brain 133(Pt 3):771–786

  33. Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, Nakayama K, Nakayama KI, Ide T et al (2006) Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol 8(11):1291–1297

    Article  CAS  PubMed  Google Scholar 

  34. Brenner C, Galluzzi L, Kepp O, Kroemer G (2013) Decoding cell death signals in liver inflammation. J Hepatol 59(3):583–594

    Article  CAS  PubMed  Google Scholar 

  35. Tang S, Le PK, Tse S, Wallace DC, Huang T (2009) Heterozygous mutation of Opa1 in Drosophila shortens lifespan mediated through increased reactive oxygen species production. PLoS One 4(2), e4492

    Article  PubMed  PubMed Central  Google Scholar 

  36. Yarosh W, Monserrate J, Tong JJ, Tse S, Le PK, Nguyen K, Brachmann CB, Wallace DC et al (2008) The molecular mechanisms of OPA1-mediated optic atrophy in Drosophila model and prospects for antioxidant treatment. PLoS Genet 4(1), e6

    Article  PubMed  PubMed Central  Google Scholar 

  37. Chen L, Liu T, Tran A, Lu X, Tomilov AA, Davies V, Cortopassi G, Chiamvimonvat N et al (2012) OPA1 mutation and late-onset cardiomyopathy: mitochondrial dysfunction and mtDNA instability. J Am Heart Assoc 1(5), e003012

    Article  PubMed  PubMed Central  Google Scholar 

  38. Sanderson TH, Raghunayakula S, Kumar R (2015) Release of mitochondrial Opa1 following oxidative stress in HT22 cells. Mol Cell Neurosci 64:116–122

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We thank all participants in this study. We thank Miss Dandan Yu and Dr. Deng-Feng Zhang for the technical assistance. This study was supported by National Natural Science Foundation of China (grant number 81200725) and the Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB02020003).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yong-Gang Yao.

Ethics declarations

Written informed consents conforming to the tenets of the Declaration of Helsinki were obtained from each participant prior to the study. The Institutional Review Boards of the Zhongshan Ophthalmic Center and the Kunming Institute of Zoology approved this study.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Table 1

(DOC 62 kb)

Supplementary Table 2

(DOC 35 kb)

Supplementary Table 3

(XLSX 26 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, AM., Bi, R., Hu, QX. et al. The OPA1 Gene Mutations Are Frequent in Han Chinese Patients with Suspected Optic Neuropathy. Mol Neurobiol 54, 1622–1630 (2017). https://doi.org/10.1007/s12035-016-9771-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-016-9771-z

Keywords

Navigation